Navigation Links
No Clear Evidence for Ultra-Low Cholesterol Targets?

Americans have been trying to get their cholesterol levels down for decades, ever since studies showed a strong link between high cholesterol and heart disease//. But in recent years, experts have suggested that some people should aim even lower, recently recommending very low levels of the type of cholesterol called low-density lipoprotein for some high-risk people — even if it means they had to take multiple medications to get there.

Not so fast, says a team of researchers from the VA Ann Arbor Healthcare System and the University of Michigan Health System in a new paper in the October Annals of Internal Medicine.

After performing an exhaustive review of existing research on LDL cholesterol and heart health, they conclude that there is no scientifically valid evidence to support the ultra-low LDL target of 70 milligrams/deciliter for very high-risk patients that has been advocated by some members of the federal government’s National Cholesterol Education Program. Further, they suggest that the evidence previously cited to support an LDL goal of less than 100mg/dL for high risk patients also has major flaws.

That evidence may come someday, but until that day, it may be better for society to concentrate less on cholesterol and more on getting people with multiple heart disease risk factors on medications called statins — regardless of their cholesterol levels. Statins are great at lowering a person’s LDL cholesterol, but it is not yet clear if lowering cholesterol is the main reason that statins prevent heart attacks and save lives. A focus on statin therapy may provide more public benefit than focusing on getting high-risk patients’ levels as low as they can go using multiple drugs.

“Our review suggests that we in the medical community have misunderstood the scientific evidence on whether very low LDL is important, or whether adequate doses of statins are what is really important,” says lead author Rodney Hayward, M.D
'"/>




Page: 1 2 3 4

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. 21 Women With Breast Cancer Given All Clear By Radiologist
3. The Decks Cleared For HRT - Safe for Menopause Symptoms
4. Laser Used To Clear Blocked Arteries Preventing Amputation
5. Drug Addicts To Prove ‘Child-Caring Capabilities’ By Clearing Drug Tess
6. Neck Artery Treatment Apart From Clearing Plaques Boosts Memory
7. Doctor Cleared Of Charges of Killing a baby
8. New Study Confers All Clear Status On Letrozole, Infertility Drug
9. Nurses Are Furious but the Exact Reason Is Not Clear
10. Helium And MRI Scanning Clearly Detects Smoker Lungs – Research Find
11. Baby Acne Clears Up On Its Own
Post Your Comments:
(Date:7/25/2008)...liance to be presented at Fenway Park ...y 25 /PRNewswire/ -- CVS/pharmacy announced today,...4 million in just 21 days,through its annual in-st...,the seventh year of the annual fundraising effort...for ALS research. This year,s fundraiser took,plac...
(Date:7/25/2008)...gus can cause immune system changes , , ...ence linking gastroesophageal reflux disease (GERD...y Medical Center researchers. , An association ...1970s, and since then studies have shown that betw...lso experience GERD symptoms. But the actual link ...
(Date:7/25/2008)...am delivers immediate cost savings for http://www...to language interpreters] to firms switching lang... , Washington, D.C. (Vocu...nc.com/index.html [(Language Learning Enterprises...anslation, and language instruction services to th...
(Date:7/25/2008)...ou are an Olympian, Professional Athlete, Elite Am...u Need to Know about Hydration to Boost Sports Per...r , Marina del Rey, Calif...tes are heading to Beijing following years of inte...pes of capturing an Olympic medal and securing the...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...ster-child of a new generation of cancer drugs aim...dangerous to the heart.// Not only that, but other...hibitors – could lead to heart problems as well, s...slational Medicine at Jefferson Medical College in...
...ed to be the most likely cause of the salmonella o... year according to the Government's// health watch...t contaminated chocolate bars and Easter eggs were...reased food poisoning cases in the spring and earl...
...even alcoholic beverages a week may live longer wi... do not drink, according to a latest study. // Th...iversity of Florida, showed that when compared wit...who drank lightly to moderately had a 26 per cent ...
... often called as the ‘fat controller’ could offer ...rchers from the University of Dundee have claimed ... diabetes and obesity. Dr Anil Mehta the head of t...ee University said that the findings could improve...
Other Medicine News:Health News:"Miracle" Cancer Drug Gleevec Can be Toxic to the Heart 2Health News:"Miracle" Cancer Drug Gleevec Can be Toxic to the Heart 3Health News:Cadbury Blamed for Salmonella Outbreak 2Health News:Protein May Offer New Hope For Treatment Of Cystic Fibrosis 2
(Date:7/22/2008)...er 293-patient European, trial -, http://www.cr... MONTREAL, July 22 / CryoCa...therapy products to treat cardiac,arrhythmias, tod...m three,European study centers using the Company,s...lier today in the Journal of the American College ...
(Date:7/22/2008)...t Initiative bring MJFF,s,current active industry ...09, NEW YORK, July 22 /PRNewswire-USNewswire/ -- ...ormative treatments and a cure for Parkinson,s,dis...s Research has awarded,$2.7 million in total fundi... granted under MJFF,s Therapeutics Development Ini...
(Date:7/22/2008)...of Treating Patients with ...SI, South Korea, July 22 /-,Jennerex,... its South,Korean partner Green Cross Corp., annou...ical trial of its first-in-class lead product JX-5...d and resulted in clear,anti-cancer efficacy in pa...
(Date:7/22/2008)...R) Resulted in Significant, Reductions in A1C in P...hm Used, BRIDGEW...he "Adjust to,Target in Type 2 Diabetes: Compariso...or Adjustment of Mealtime Insulin Glulisine" study...ion,s (ADA) medical journal,Diabetes Care. This s...
Breaking Medicine Technology:CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Administration Anesthetized to Ailments of Nations Children 4103 1Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 1Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 2Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 3Cognizant to Acquire marketRx a Leading Provider of Life Sciences Market Analytics 1358 4Coherent Inc to Webcast Fourth Fiscal Quarter 2007 Results 1355 1Video 3A Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck 1352 1Video 3A Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck 1352 2
...tion in Intestinal Adenomas Suggesting,Possible Be...,Cancer, EL DORADO HILLS, Calif., March 07, 2007 /...s of a study on the effect of rice bran,on the num...ished,in the January 9, 2007 online edition of the...t the Department of Cancer Studies and,Molecular M...
...of Higher Doses to Further Reduce Antibodies,to Do...wswire-FirstCall/ -- La Jolla,Pharmaceutical Compa...ts from its ongoing double-blind, placebo-controll...s sodium), its drug,candidate for systemic lupus e...im antibody data indicate that patients treated,wi...
Other Medicine Technology:British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 2British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 3British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 4La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 7
The GENIE is the proven electrophoretic transfer apparatus incorporating state-of-the-art plate electrodes for the ultimate in field uniformity. Its design allows for a very close positioning of the
The HEP-3, with a transfer area of 35cmW x 45cmL, is designed specifically for the transfer of nucleic acids from sequencing gels to nylon membranes.
The Trans-Blot SD semi-dry transfer cell allows fast, efficient and economical blotting. Using a platinum-coated titanium plate as the anode and a stainless steel plate as the cathode, the Trans-Blot
...A and RNA from agarose gels to hybridization membr...nd efficiency of transfer by allowing high pressur...em allowing electrophoresis, gel treatment, transf...rs required for conventional methods ,Positive pre...
Medicine Products: